CAUMZ Trademark

Trademark Overview

On Tuesday, October 22, 2019, a trademark application was filed for CAUMZ with the United States Patent and Trademark Office. The USPTO has given the CAUMZ trademark a serial number of 88664222. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, March 28, 2023. This trademark is owned by TETRA BIO-PHARMA INC.. The CAUMZ trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for pain relief in the field of advanced cancer and breakthrough pain
caumz

General Information

Serial Number88664222
Word MarkCAUMZ
Filing DateTuesday, October 22, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, March 28, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicespharmaceutical preparations for pain relief in the field of advanced cancer and breakthrough pain

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 28, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTETRA BIO-PHARMA INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLongueuil, Quebec J4H2X7
CA

Trademark Events

Event DateEvent Description
Wednesday, March 29, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, March 28, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, March 28, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, September 7, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, September 7, 2022INQUIRY TO SUSPENSION E-MAILED
Wednesday, September 7, 2022SUSPENSION INQUIRY WRITTEN
Tuesday, May 24, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, May 24, 2022LETTER OF SUSPENSION E-MAILED
Tuesday, May 24, 2022SUSPENSION LETTER WRITTEN
Tuesday, April 26, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 25, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 25, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 29, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, October 25, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 25, 2021NON-FINAL ACTION E-MAILED
Monday, October 25, 2021NON-FINAL ACTION WRITTEN
Saturday, April 24, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, April 24, 2021LETTER OF SUSPENSION E-MAILED
Saturday, April 24, 2021SUSPENSION LETTER WRITTEN
Thursday, April 22, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 22, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 20, 2021ASSIGNED TO LIE
Wednesday, January 13, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, July 28, 2020NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, July 28, 2020INQUIRY TO SUSPENSION E-MAILED
Tuesday, July 28, 2020SUSPENSION INQUIRY WRITTEN
Tuesday, January 28, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, January 28, 2020LETTER OF SUSPENSION E-MAILED
Tuesday, January 28, 2020SUSPENSION LETTER WRITTEN
Tuesday, January 28, 2020ASSIGNED TO EXAMINER
Monday, October 28, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 25, 2019NEW APPLICATION ENTERED

Related Keywords

caumz pain cancer breakthrough advanced relief preparations pharmaceutical field